GS-621763

GS-621763, an orally bioavailable prodrug of GS-441524, shows a dose-dependent antiviral effect on SARS-CoV-2 reporter virus expressing nanoluciferase (SARS-CoV-2 nLUC) replication with an EC50 of 2.8 μM, also inhibits reporter SARS-CoV-2 expressing firefly luciferase (SARS-CoV-2 Fluc) replication with EC50 of 0.125 μM. 

Price Not Available 5mg GS-621763 Supplier Page
Trivial name N/A
Catalog Number E1112
Molecular Formula C24H31N5O7
CAS# 2647442-13-3
SMILES CC(C)C(=O)OCC1OC(C#N)(C(OC(=O)C(C)C)C1OC(=O)C(C)C)C2=CC=C3[N]2N=CN=C3N
Size 5mg
Supplier Page http://www.selleckchem.com/products/gs-621763.html
Additional Information https://file.selleck.cn/downloads/struct/e1112-gs-621763-chemical-structure.gif